David Nishimoto
Self Efficacy with Ai - Power Bursts, Myth Destroyers, Hope through benefit incentives
Self Efficacy with Ai remains the core app in David S. Nishimoto’s collection. It directly supports building powerful habits, overcoming addictive behaviors, strengthening personal agency, and finding sustained hope through faith in Jesus Christ. It delivers daily “Power Bursts,” myth destroyers, motivational insights, and practical tracking tools to reinforce self-belief and lasting transformation. Louise AI Stop Smoking (Ai Stop Smoking Relapse) serves as a dedicated Quit Smoking AI Coach. It provides instant, personalized support during intense cravings, visual progress tracking
Author
David Nishimoto
Category
Podcast website
Latest episode
Jun 20, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Ai Speak Japanese Fluently 19.99 30.03.2026 0:23
buy on the app store https://apps.apple.com/us/app/ai-speak-japanese-fluently/id6759203292
Self Efficacy with Ai 19.99 29.03.2026 13:29
buy on the app store
Louise ai wealth compass demonstrated 19.99 29.03.2026 3:44
buy on the app store
Claude Opus head count cut and profit margins predictions 19.02.2026 12:36
Claude opus will automate tasks and reduce hours to perform work
Job Cuts from 2026 thru 2030 due to ai disruption and corporate restructuring 18.02.2026 19:47
Ai distruption will be about 4% head count reduction as large companies begin restructuring labor force
Ai Job Disruptions in 2026 and Job Stabilization in 2027 16.02.2026 22:20
Jobs will stabilize in 2027
Pony.ai and nvidia thor opportunity 12.02.2026 1:55
Ecosystem developments further support this inference: partners like Lenovo have built Thor-based controllers (e.g., HPC 3.0 in WeRide's GXR robotaxi, the world's first mass-produced L4 system on Thor), and integrations with Uber facilitate upgrades from Orin to Thor for enhanced end-to-end AI. Pony.ai 's history of close co-development with NVIDIA—from earlier Pegasus to Orin—logicall...
Leaders anticipate the future 11.02.2026 11:47
they provide strategy and resources to build the future
The growth of n8m 08.02.2026 2:28
n8n growth has been incredible as more companies are racing to automate
Persecuting Behaviors 08.02.2026 13:53
Persecuting behaviors says "your not important" to the other person
Louise Ai Chat 29.99 - Will there be more Jobs over the next 25 years 07.02.2026 17:41
Louise Ai Chat 29.99 on the App Store
Louise Ai Chat $29.99. - Management skills over the next 25 years 07.02.2026 17:53
buy on the App Store Louise Ai Career Portal
Louise Ai Chat $29.99 - Jobs over the next 25 years 06.02.2026 31:09
buy on the app store
Louise Ai Chat - Learning how to say No 05.02.2026 7:19
buy at the App Store 29.99
Louise Ai chat - one minute daily removes the stress 04.02.2026 4:56
buy on the App Store 29.99
A demonstration of Louise Ai Chat 29.99 04.02.2026 13:17
https://apps.apple.com/us/app/louise-ai-chat/id6749811490 buy on the App Store for 29.99
Louise Ai Chat - Focus on empathy and not quick fixes 03.02.2026 6:37
foster deeper relationships and connections
Louise Ai agent : Tesla 2026 Predictions 02.02.2026 2:34
esla's potential ascent to a $900 per share stock price by the end of 2026, starting from its current level around $431 as of late January 2026, hinges on a confluence of aggressive production scaling, margin expansion, and market enthusiasm that far exceeds consensus analyst expectations. This target implies a market capitalization approaching $2.9 trillion on roughly 3.2 billion diluted shar...
Louise Ai Chat : Rescuing Behaviors 02.02.2026 13:22
Louise Ai Chat (29.99 on the App Store) Addressing your question about why doing for others what they can do for themselves may be damaging brings us into the realm of "pathological altruism" and the unintended consequences of our help. While it often stems from a place of genuine care, this kind of assistance can inadvertently foster feelings of guilt, obligation, or even a sense of bei...
Louise Ai Chat - Talk on Futility 26.01.2026 10:31
Louise Ai Chat (buy on the App Store for 19.99 dollars
Louise Ai agent : The 1 GW PEM proposal 04.01.2026 2:05
Air Products stands as the world's largest producer of hydrogen, operating an unmatched global network of production facilities and distribution infrastructure. The company's blue hydrogen complexes in Louisiana and Texas produce massive volumes of hydrogen with integrated carbon capture, achieving near-zero emissions at scale. Its Lake Charles plant alone represents a multi-billion-dollar...
What about Symbotic 06.12.2025 2:19
Symbotic is transforming warehouse and distribution-center operations. The company designs, builds, and operates fully automated, robotics-and-software platforms primarily for large North American retailers and wholesalers, with Walmart historically accounting for more than 80% of revenue. The single most compelling element of the bull case is Symbotic’s $22.5 billion backlog of remaining performa...
Louise ai agent: Nvidia (batman) and IonQ (Robin) Dynamic duel 06.12.2025 2:05
IonQ and NVIDIA as a High-Conviction Pair for the Next Decade of Computing The simultaneous rise of artificial intelligence and quantum computing represents the most significant technological paradigm shift since the commercialization of the internet. NVIDIA remains the dominant provider of AI training and inference infrastructure, while IonQ has established itself as the leading pure-play public...
Louise ai agent: Why I am hopeful about Tiziana Life Sciences 03.12.2025 2:23
Tiziana Life Sciences (TLSA) aims to deliver Foralumab, the world’s first intranasal anti-CD3 immunotherapy, as a disease-modifying, at-home treatment that halts neuroinflammation and progression in currently incurable conditions—starting with non-active secondary progressive MS (SPMS), where it has shown up to 50% reduction in brain microglia activation via PET imaging in Phase 2a, then expanding...
Louise ai agent : Why I like Palvella Therapeutics 03.12.2025 2:24
Palvella Therapeutics is a late-clinical-stage biopharmaceutical company built entirely around its patented QTORIN™ anhydrous gel delivery platform, which solves the decades-old problem of delivering high concentrations of rapamycin (and related mTOR inhibitors) deep into the skin while keeping systemic exposure essentially zero. Every single asset in the pipeline leverages this same core technolo...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.